Page last updated: 2024-09-03

ta 993 and Hemolysis

ta 993 has been researched along with Hemolysis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, H; Karasawa, T; Katoh, M; Odawara, A1

Other Studies

1 other study(ies) available for ta 993 and Hemolysis

ArticleYear
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
    Thrombosis research, 2001, Oct-15, Volume: 104, Issue:2

    Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Hemorheology; Humans; Phospholipids; Platelet Aggregation Inhibitors; Rats; Ticlopidine

2001